{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:28:06Z","timestamp":1792042086917,"version":"4.4.0"},"reference-count":148,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.jsbmb.2009.12.010","type":"journal-article","created":{"date-parts":[[2009,12,29]],"date-time":"2009-12-29T04:07:10Z","timestamp":1262059630000},"page":"42-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":275,"title":["Insulin and hyperandrogenism in women with polycystic ovary syndrome"],"prefix":"10.1016","volume":"122","author":[{"given":"Catherine G.","family":"Baptiste","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claude","family":"Battista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9anne","family":"Trottier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Patrice","family":"Baillargeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jsbmb.2009.12.010_bib0005","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil. Steril."},{"issue":"10","key":"10.1016\/j.jsbmb.2009.12.010_bib0010","first-page":"1012","article-title":"Use of insulin sensitizers in polycystic ovarian syndrome","volume":"6","author":"Baillargeon","year":"2005","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.jsbmb.2009.12.010_bib0015","series-title":"Current Issues in Endocrinology and Metabolism: Polycystic Ovary Syndrome","article-title":"Diagnostic criteria for polycystic ovary syndrome: towards a rational approach","author":"Zawadzki","year":"1992"},{"issue":"1","key":"10.1016\/j.jsbmb.2009.12.010_bib0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Anon.","year":"2004","journal-title":"Fertil. Steril."},{"issue":"11","key":"10.1016\/j.jsbmb.2009.12.010_bib0025","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2009.12.010_bib0030","doi-asserted-by":"crossref","DOI":"10.1080\/09513590903015619","article-title":"The role of genes in the polycystic ovary syndrome: predisposition and mechanisms","author":"Deligeoroglou","year":"2009","journal-title":"Gynecol. Endocrinol."},{"issue":"7","key":"10.1016\/j.jsbmb.2009.12.010_bib0035","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1503\/cmaj.060607","article-title":"Suitability of recommended limits for fasting glucose tests in women with polycystic ovary syndrome","volume":"176","author":"Gagnon","year":"2007","journal-title":"CMAJ"},{"issue":"1","key":"10.1016\/j.jsbmb.2009.12.010_bib0040","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1056\/NEJMct0707092","article-title":"Metformin for the treatment of the polycystic ovary syndrome","volume":"358","author":"Nestler","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.jsbmb.2009.12.010_bib0045","first-page":"210","article-title":"Early onset adiposity: a pathway to polycystic ovary syndrome in adolescents?","volume":"6","author":"Diamanti-Kandarakis","year":"2007","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.jsbmb.2009.12.010_bib0050","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.mce.2006.12.001","article-title":"Adrenal cholesterol utilization","volume":"265\u2013266","author":"Kraemer","year":"2007","journal-title":"Mol. Cell. Endocrinol."},{"issue":"1","key":"10.1016\/j.jsbmb.2009.12.010_bib0055","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1023\/A:1012748718150","article-title":"Multiple signal transduction pathways regulate ovarian steroidogenesis","volume":"3","author":"Wood","year":"2002","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"11","key":"10.1016\/j.jsbmb.2009.12.010_bib0060","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.4161\/cc.5.11.2803","article-title":"Ovarian steroids: the good, the bad, and the signals that raise them","volume":"5","author":"Jamnongjit","year":"2006","journal-title":"Cell Cycle"},{"issue":"6","key":"10.1016\/j.jsbmb.2009.12.010_bib0065","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1210\/er.2003-0030","article-title":"Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones","volume":"25","author":"Payne","year":"2004","journal-title":"Endocr. Rev."},{"issue":"1\u20135","key":"10.1016\/j.jsbmb.2009.12.010_bib0070","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jsbmb.2007.05.001","article-title":"Mechanisms in the regulation of aromatase in developing ovary and placenta","volume":"106","author":"Mendelson","year":"2007","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"3","key":"10.1016\/j.jsbmb.2009.12.010_bib0075","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/jemt.10331","article-title":"Adrenocortical zonation and ACTH","volume":"61","author":"Vinson","year":"2003","journal-title":"Microsc. Res. Tech."},{"issue":"3","key":"10.1016\/j.jsbmb.2009.12.010_bib0080","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/humrep\/17.3.620","article-title":"Ovarian and adrenal steroid production: regulatory role of LH\/HCG","volume":"17","author":"Piltonen","year":"2002","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.jsbmb.2009.12.010_bib0085","doi-asserted-by":"crossref","unstructured":"C.R. Parker Jr, Androgens throughout the life of women, in: Androgen Excess Disorders in Women, 2nd ed., Humana Press, Totowa, NJ, 2006, pp. 35\u201348.","DOI":"10.1007\/978-1-59745-179-6_3"},{"issue":"10","key":"10.1016\/j.jsbmb.2009.12.010_bib0090","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1210\/jcem.86.10.7900","article-title":"The postmenopausal ovary is not a major androgen-producing gland","volume":"86","author":"Couzinet","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.jsbmb.2009.12.010_bib0095","first-page":"3558","article-title":"The zona reticularis is the site of biosynthesis of dehydroepiandrosterone and dehydroepiandrosterone sulfate in the adult human adrenal cortex resulting from its low expression of 3 beta-hydroxysteroid dehydrogenase","volume":"81","author":"Endoh","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2009.12.010_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000134751","article-title":"Steroidogenic enzymes","volume":"13","author":"Miller","year":"2008","journal-title":"Endocr. Dev."},{"issue":"3","key":"10.1016\/j.jsbmb.2009.12.010_bib0105","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/jemt.10339","article-title":"ACTH modulation of transcription factors responsible for steroid hydroxylase gene expression in the adrenal cortex","volume":"61","author":"Sewer","year":"2003","journal-title":"Microsc. Res. Tech."},{"issue":"1\u20132","key":"10.1016\/j.jsbmb.2009.12.010_bib0110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0303-7207(02)00363-5","article-title":"Androgen biosynthesis from cholesterol to DHEA","volume":"198","author":"Miller","year":"2002","journal-title":"Mol. Cell. Endocrinol."},{"issue":"5","key":"10.1016\/j.jsbmb.2009.12.010_bib0115","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1021\/bi9821059","article-title":"Biochemical differences between rat and human cytochrome P450c17 support the different steroidogenic needs of these two species","volume":"38","author":"Brock","year":"1999","journal-title":"Biochemistry"},{"issue":"1C","key":"10.1016\/j.jsbmb.2009.12.010_bib0120","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/0022-4731(83)90039-0","article-title":"Steroid biosynthesis by zona fasciculata and zona reticularis cells purified from the mammalian adrenal cortex","volume":"19","author":"Hyatt","year":"1983","journal-title":"J. Steroid Biochem."},{"issue":"6","key":"10.1016\/j.jsbmb.2009.12.010_bib0125","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/(SICI)1097-0029(19970315)36:6<445::AID-JEMT2>3.0.CO;2-H","article-title":"Light and electron microscopic immunohistochemistry of the localization of adrenal steroidogenic enzymes","volume":"36","author":"Ishimura","year":"1997","journal-title":"Microsc. Res. Tech."},{"issue":"5","key":"10.1016\/j.jsbmb.2009.12.010_bib0130","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1210\/en.2007-1527","article-title":"Pathways leading to phosphorylation of p450c17 and to the posttranslational regulation of androgen biosynthesis","volume":"149","author":"Tee","year":"2008","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.jsbmb.2009.12.010_bib0135","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1530\/jrf.0.0850163","article-title":"Immunolocalization of aromatase, 17 alpha-hydroxylase and side-chain-cleavage cytochromes P-450 in the human ovary","volume":"85","author":"Sasano","year":"1989","journal-title":"J. Reprod. Fertil."},{"issue":"2","key":"10.1016\/j.jsbmb.2009.12.010_bib0140","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/en.2002-220813","article-title":"Molecular target of endocrine disruption in human luteinizing granulosa cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin: inhibition of estradiol secretion due to decreased 17alpha-hydroxylase\/17,20-lyase cytochrome P450 expression","volume":"144","author":"Moran","year":"2003","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.jsbmb.2009.12.010_bib0145","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0039-128X(96)00172-9","article-title":"The regulation of 17,20 lyase activity","volume":"62","author":"Miller","year":"1997","journal-title":"Steroids"},{"issue":"3","key":"10.1016\/j.jsbmb.2009.12.010_bib0150","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0015-0282(16)54890-0","article-title":"Long-term administration of gonadotropin-releasing hormone agonist and dexamethasone: assessment of the adrenal role in ovarian dysfunction","volume":"57","author":"Cedars","year":"1992","journal-title":"Fertil. Steril."},{"issue":"9","key":"10.1016\/j.jsbmb.2009.12.010_bib0155","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1056\/NEJM198903023200904","article-title":"Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome","volume":"320","author":"Barnes","year":"1989","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.jsbmb.2009.12.010_bib0160","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/0002-9378(92)91779-A","article-title":"Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?","volume":"167","author":"Carmina","year":"1992","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.jsbmb.2009.12.010_bib0165","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM199207163270304","article-title":"Detection of functional ovarian hyperandrogenism in women with androgen excess","volume":"327","author":"Ehrmann","year":"1992","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jsbmb.2009.12.010_bib0170","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1365-2265.1997.2321049.x","article-title":"Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome","volume":"47","author":"Gilling-Smith","year":"1997","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"1","key":"10.1016\/j.jsbmb.2009.12.010_bib0175","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0015-0282(16)47961-6","article-title":"The prevalence and significance of elevated dehydroepiandrosterone sulfate levels in anovulatory women","volume":"42","author":"Hoffman","year":"1984","journal-title":"Fertil. Steril."},{"issue":"4","key":"10.1016\/j.jsbmb.2009.12.010_bib0180","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1210\/jcem-55-4-768","article-title":"Long term effects of nightly dexamethasone administration in patients with polycystic ovarian disease","volume":"55","author":"Lachelin","year":"1982","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.jsbmb.2009.12.010_bib0185","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1210\/jcem-70-4-1096","article-title":"Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism","volume":"70","author":"Rittmaster","year":"1990","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.jsbmb.2009.12.010_bib0190","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1210\/jcem-72-1-83","article-title":"A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome","volume":"72","author":"Nestler","year":"1991","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.jsbmb.2009.12.010_bib0195","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3109\/09513598709023614","article-title":"Adrenal cortex and type II polycystic ovary syndrome","volume":"1","author":"Devesa","year":"1987","journal-title":"Gynecol. Endocrinol."},{"issue":"2","key":"10.1016\/j.jsbmb.2009.12.010_bib0200","first-page":"556","article-title":"17 alpha-Hydroxyprogesterone responses to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome offer dietary weight loss","volume":"82","author":"Jakubowicz","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.jsbmb.2009.12.010_bib0205","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJM199608293350902","article-title":"Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome","volume":"335","author":"Nestler","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.jsbmb.2009.12.010_bib0210","first-page":"4075","article-title":"Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens","volume":"82","author":"Nestler","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.jsbmb.2009.12.010_bib0215","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1210\/jcem.87.4.8398","article-title":"Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia\/insulin resistance","volume":"87","author":"Arslanian","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.jsbmb.2009.12.010_bib0220","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/humrep\/deh145","article-title":"Effect of pioglitazone treatment on the adrenal androgen response to corticotrophin in obese patients with polycystic ovary syndrome","volume":"19","author":"Guido","year":"2004","journal-title":"Hum. Reprod."},{"issue":"6","key":"10.1016\/j.jsbmb.2009.12.010_bib0225","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0015-0282(99)00407-0","article-title":"Effects of metformin on adrenal steroidogenesis in women with polycystic ovary syndrome","volume":"72","author":"la Marca","year":"1999","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.jsbmb.2009.12.010_bib0230","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.fertnstert.2006.11.076","article-title":"Pioglitazone reduces the adrenal androgen response to corticotropin-releasing factor without changes in ACTH release in hyperinsulinemic women with polycystic ovary syndrome","volume":"88","author":"Romualdi","year":"2007","journal-title":"Fertil. Steril."},{"issue":"4","key":"10.1016\/j.jsbmb.2009.12.010_bib0235","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.fertnstert.2004.02.127","article-title":"Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity","volume":"82","author":"Baillargeon","year":"2004","journal-title":"Fertil. Steril."},{"issue":"4","key":"10.1016\/j.jsbmb.2009.12.010_bib0240","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1124\/mol.105.012260","article-title":"Activation of mitogen-activated protein kinases by peroxisome proliferator-activated receptor ligands: an example of nongenomic signaling","volume":"68","author":"Gardner","year":"2005","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.jsbmb.2009.12.010_bib0245","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1210\/jc.2005-1804","article-title":"Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin?","volume":"91","author":"Baillargeon","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2\u20134","key":"10.1016\/j.jsbmb.2009.12.010_bib0250","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1515\/JBCPP.1998.9.2-4.89","article-title":"The insulin receptor\u2014a critical link in glucose homeostasis and insulin action","volume":"9","author":"Patti","year":"1998","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"issue":"4","key":"10.1016\/j.jsbmb.2009.12.010_bib0255","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1074\/jbc.274.4.1865","article-title":"Signaling mechanisms that regulate glucose transport","volume":"274","author":"Czech","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.jsbmb.2009.12.010_bib0260","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.diabres.2008.11.035","article-title":"Classical PKC is not associated with defective insulin signaling in patients with impaired glucose tolerance","volume":"83","author":"Kim do","year":"2009","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"9","key":"10.1016\/j.jsbmb.2009.12.010_bib0265","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S1043-2760(00)00323-4","article-title":"Free fatty acids and pathogenesis of type 2 diabetes mellitus","volume":"11","author":"Bergman","year":"2000","journal-title":"Trends Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.jsbmb.2009.12.010_bib0270","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1097-2765(05)00015-8","article-title":"Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction","volume":"6","author":"Michael","year":"2000","journal-title":"Mol. Cell"},{"issue":"24","key":"10.1016\/j.jsbmb.2009.12.010_bib0275","doi-asserted-by":"crossref","first-page":"13656","DOI":"10.1073\/pnas.96.24.13656","article-title":"Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes","volume":"96","author":"Shimomura","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.jsbmb.2009.12.010_bib0280","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1074\/jbc.273.1.215","article-title":"Identification of novel phosphorylation sites in hormone-sensitive lipase that are phosphorylated in response to isoproterenol and govern activation properties in vitro","volume":"273","author":"Anthonsen","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.jsbmb.2009.12.010_bib0285","doi-asserted-by":"crossref","first-page":"E635","DOI":"10.1152\/ajpendo.90596.2008","article-title":"Protein kinase B activity is required for the effects of insulin on lipid metabolism in adipocytes","volume":"296","author":"Berggreen","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.jsbmb.2009.12.010_bib0290","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1128\/MCB.01489-08","article-title":"Glucose effects on beta-cell growth and survival require activation of insulin receptors and insulin receptor substrate 2","volume":"29","author":"Assmann","year":"2009","journal-title":"Mol. Cell. Biol."},{"issue":"6","key":"10.1016\/j.jsbmb.2009.12.010_bib0295","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1095\/biolreprod.105.049908","article-title":"Insulin and oxidative stress modulate proliferation of rat ovarian theca-interstitial cells through diverse signal transduction pathways","volume":"74","author":"Kwintkiewicz","year":"2006","journal-title":"Biol. Reprod."},{"issue":"9","key":"10.1016\/j.jsbmb.2009.12.010_bib0300","first-page":"3110","article-title":"Selective insulin resistance in the polycystic ovary syndrome","volume":"84","author":"Book","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.jsbmb.2009.12.010_bib0305","first-page":"577","article-title":"Cellular mechanisms of insulin resistance in polycystic ovarian syndrome","volume":"75","author":"Ciaraldi","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.jsbmb.2009.12.010_bib0310","doi-asserted-by":"crossref","first-page":"E392","DOI":"10.1152\/ajpendo.2001.281.2.E392","article-title":"Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS)","volume":"281","author":"Dunaif","year":"2001","journal-title":"Am. J. Physiol Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.jsbmb.2009.12.010_bib0315","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.fertnstert.2006.12.055","article-title":"Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity","volume":"88","author":"Baillargeon","year":"2007","journal-title":"Fertil. Steril."},{"issue":"4 Pt 1","key":"10.1016\/j.jsbmb.2009.12.010_bib0320","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/0002-9378(90)90698-7","article-title":"Suppression of serum insulin level by diazoxide does not alter serum testosterone or sex hormone-binding globulin levels in healthy, nonobese women","volume":"163","author":"Nestler","year":"1990","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"7","key":"10.1016\/j.jsbmb.2009.12.010_bib0325","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.molmed.2006.05.006","article-title":"Molecular mechanisms of insulin resistance in polycystic ovary syndrome","volume":"12","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Trends Mol. Med."},{"issue":"2","key":"10.1016\/j.jsbmb.2009.12.010_bib0330","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1172\/JCI118126","article-title":"Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome","volume":"96","author":"Dunaif","year":"1995","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.jsbmb.2009.12.010_bib0335","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1210\/jc.2002-020363","article-title":"Decreased insulin receptor (IR) autophosphorylation in fibroblasts from patients with PCOS: effects of serine kinase inhibitors and IR activators","volume":"87","author":"Li","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.jsbmb.2009.12.010_bib0340","first-page":"1421","article-title":"Cellular insulin resistance in adipocytes from obese polycystic ovary syndrome subjects involves adenosine modulation of insulin sensitivity","volume":"82","author":"Ciaraldi","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.jsbmb.2009.12.010_bib0345","first-page":"1147","article-title":"Impaired adipocyte lipolysis in nonobese women with the polycystic ovary syndrome: a possible link to insulin resistance?","volume":"82","author":"Ek","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.jsbmb.2009.12.010_bib0350","doi-asserted-by":"crossref","first-page":"E1047","DOI":"10.1152\/ajpendo.00361.2004","article-title":"Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling","volume":"288","author":"Corbould","year":"2005","journal-title":"Am. J. Physiol Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.jsbmb.2009.12.010_bib0355","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1007\/s00125-006-0312-6","article-title":"Partial rescue of in vivo insulin signalling in skeletal muscle by impaired insulin clearance in heterozygous carriers of a mutation in the insulin receptor gene","volume":"49","author":"Hojlund","year":"2006","journal-title":"Diabetologia"},{"issue":"45","key":"10.1016\/j.jsbmb.2009.12.010_bib0360","doi-asserted-by":"crossref","first-page":"37803","DOI":"10.1074\/jbc.M503897200","article-title":"Characterization of the role of the Rab GTPase-activating protein AS160 in insulin-regulated GLUT4 trafficking","volume":"280","author":"Larance","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.jsbmb.2009.12.010_bib0365","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1172\/JCI200317592","article-title":"Critical role of galectin-3 in phagocytosis by macrophages","volume":"112","author":"Sano","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.jsbmb.2009.12.010_bib0370","first-page":"4406","article-title":"Insulin stimulation of GLUT4 exocytosis, but not its inhibition of endocytosis, is dependent on RabGAP AS160","volume":"15","author":"Zeigerer","year":"2004","journal-title":"Mpl. Biol. Cell"},{"issue":"2","key":"10.1016\/j.jsbmb.2009.12.010_bib0375","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2337\/db07-0706","article-title":"Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment","volume":"57","author":"Hojlund","year":"2008","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.jsbmb.2009.12.010_bib0380","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.2337\/diabetes.50.10.2210","article-title":"A role for protein phosphatase 2A-like activity, but not atypical protein kinase Czeta, in the inhibition of protein kinase B\/Akt and glycogen synthesis by palmitate","volume":"50","author":"Cazzolli","year":"2001","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.jsbmb.2009.12.010_bib0385","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S0026-0495(98)90348-1","article-title":"Lack of insulin resistance in fibroblasts from subjects with polycystic ovary syndrome","volume":"47","author":"Ciaraldi","year":"1998","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.jsbmb.2009.12.010_bib0390","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0003-4266(04)95629-6","article-title":"Alteration in insulin action: role of IRS-1 serine phosphorylation in the retroregulation of insulin signalling","volume":"65","author":"Tanti","year":"2004","journal-title":"Ann. Endocrinol. (Paris)"},{"issue":"6","key":"10.1016\/j.jsbmb.2009.12.010_bib0395","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1093\/humrep\/15.6.1266","article-title":"Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome","volume":"15","author":"Morin-Papunen","year":"2000","journal-title":"Hum. Reprod."},{"issue":"9","key":"10.1016\/j.jsbmb.2009.12.010_bib0400","first-page":"2586","article-title":"Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome","volume":"80","author":"Holte","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.jsbmb.2009.12.010_bib0405","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1210\/edrv.23.2.0461","article-title":"Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes","volume":"23","author":"Lewis","year":"2002","journal-title":"Endocr. Rev."},{"issue":"2","key":"10.1016\/j.jsbmb.2009.12.010_bib0410","doi-asserted-by":"crossref","first-page":"E281","DOI":"10.1152\/ajpendo.00332.2002","article-title":"Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites","volume":"284","author":"Lam","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.jsbmb.2009.12.010_bib0415","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.2337\/diabetes.50.11.2579","article-title":"Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans","volume":"50","author":"Bachmann","year":"2001","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.jsbmb.2009.12.010_bib0420","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.diabet.2007.10.009","article-title":"Postprandial fatty acid metabolism in the development of lipotoxicity and type 2 diabetes","volume":"34","author":"Carpentier","year":"2008","journal-title":"Diabetes Metab."},{"issue":"10","key":"10.1016\/j.jsbmb.2009.12.010_bib0425","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1210\/jc.2008-0714","article-title":"Intravenous lipid and heparin infusion-induced elevation in free fatty acids and triglycerides modifies circulating androgen levels in women: a randomized, controlled trial","volume":"93","author":"Mai","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Suppl. 2","key":"10.1016\/j.jsbmb.2009.12.010_bib0430","first-page":"13","article-title":"Effects of dietary fat on androgen secretion and metabolism","volume":"6","author":"Gromadzka-Ostrowska","year":"2006","journal-title":"Reprod. Biol."},{"issue":"14","key":"10.1016\/j.jsbmb.2009.12.010_bib0435","doi-asserted-by":"crossref","first-page":"13265","DOI":"10.1074\/jbc.M414673200","article-title":"Regulation of 17,20 lyase activity by cytochrome b5 and by serine phosphorylation of P450c17","volume":"280","author":"Pandey","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"23","key":"10.1016\/j.jsbmb.2009.12.010_bib0440","doi-asserted-by":"crossref","first-page":"10619","DOI":"10.1073\/pnas.92.23.10619","article-title":"Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome","volume":"92","author":"Zhang","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"8","key":"10.1016\/j.jsbmb.2009.12.010_bib0445","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/s001250050765","article-title":"Fatty acid induced insulin resistance in rat-1 fibroblasts overexpressing human insulin receptors: impaired insulin-stimulated mitogen-activated protein kinase activity","volume":"40","author":"Usui","year":"1997","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.jsbmb.2009.12.010_bib0450","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr. Rev."},{"issue":"3","key":"10.1016\/j.jsbmb.2009.12.010_bib0455","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1210\/er.16.3.322","article-title":"Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion","volume":"16","author":"Ehrmann","year":"1995","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jsbmb.2009.12.010_bib0460","doi-asserted-by":"crossref","unstructured":"J.P. Baillargeon, Insulin action in polycystic ovary syndrome: in vivo and in vitro, in: The Polycystic Ovary Syndrome\u2014Current Concepts on Pathogenesis and Clinical Care, Springer, New York, 2007, pp. 43\u201368.","DOI":"10.1007\/978-0-387-69248-7_4"},{"issue":"2","key":"10.1016\/j.jsbmb.2009.12.010_bib0465","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1210\/me.2004-0178","article-title":"Alterations in mitogen-activated protein kinase kinase and extracellular regulated kinase signaling in theca cells contribute to excessive androgen production in polycystic ovary syndrome","volume":"19","author":"Nelson-DeGrave","year":"2005","journal-title":"Mol. Endocrinol."},{"issue":"6","key":"10.1016\/j.jsbmb.2009.12.010_bib0470","first-page":"2001","article-title":"Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system","volume":"83","author":"Nestler","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.jsbmb.2009.12.010_bib0475","first-page":"302","article-title":"Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries","volume":"81","author":"Willis","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1\u20132","key":"10.1016\/j.jsbmb.2009.12.010_bib0480","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0303-7207(98)00177-4","article-title":"Role of cytochrome P450c17 in polycystic ovary syndrome","volume":"145","author":"Qin","year":"1998","journal-title":"Mol. Cell. Endocrinol."},{"issue":"29","key":"10.1016\/j.jsbmb.2009.12.010_bib0485","doi-asserted-by":"crossref","first-page":"26380","DOI":"10.1074\/jbc.M300688200","article-title":"The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis","volume":"278","author":"Wood","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.jsbmb.2009.12.010_bib0490","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0039-128X(96)00223-1","article-title":"Induction of steroidogenic enzyme genes by insulin and IGF-I in cultured adult human adrenocortical cells","volume":"62","author":"Kristiansen","year":"1997","journal-title":"Steroids"},{"issue":"11","key":"10.1016\/j.jsbmb.2009.12.010_bib0495","first-page":"3892","article-title":"Insulin-like growth factors enhance steroidogenic enzyme and corticotropin receptor messenger ribonucleic acid levels and corticotropin steroidogenic responsiveness in cultured human adrenocortical cells","volume":"81","author":"l\u2019Allemand","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1\u20132","key":"10.1016\/j.jsbmb.2009.12.010_bib0500","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0022-4731(90)90111-5","article-title":"Differential modulation of ACTH-stimulated cortisol and androstenedione secretion by insulin","volume":"36","author":"Kramer","year":"1990","journal-title":"J. Steroid Biochem."},{"issue":"4","key":"10.1016\/j.jsbmb.2009.12.010_bib0505","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0015-0282(03)01007-0","article-title":"Selective ovary resistance to insulin signaling in women with polycystic ovary syndrome","volume":"80","author":"Wu","year":"2003","journal-title":"Fertil. Steril."},{"issue":"5 Suppl.","key":"10.1016\/j.jsbmb.2009.12.010_bib0510","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.fertnstert.2008.02.167","article-title":"Insulin resistance directly contributes to androgenic potential within ovarian theca cells","volume":"91","author":"Qu","year":"2009","journal-title":"Fertil. Steril."},{"issue":"5","key":"10.1016\/j.jsbmb.2009.12.010_bib0515","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1210\/endo-122-5-2034","article-title":"Insulin as a regulator of androgen biosynthesis by cultured rat ovarian cells: cellular mechanism(s) underlying physiological and pharmacological hormonal actions","volume":"122","author":"Hernandez","year":"1988","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.jsbmb.2009.12.010_bib0520","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1210\/endo-122-6-2518","article-title":"Characterization of insulin-like growth factor I and insulin receptors on cultured bovine adrenal fasciculata cells. Role of these peptides on adrenal cell function","volume":"122","author":"Penhoat","year":"1988","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.jsbmb.2009.12.010_bib0525","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1210\/en.2003-0329","article-title":"Insulin augmentation of 17alpha-hydroxylase activity is mediated by phosphatidyl inositol 3-kinase but not extracellular signal-regulated kinase-1\/2 in human ovarian theca cells","volume":"145","author":"Munir","year":"2004","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.jsbmb.2009.12.010_bib0530","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.tem.2006.01.003","article-title":"Human ovarian theca cells in culture","volume":"17","author":"Wickenheisser","year":"2006","journal-title":"Trends Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.jsbmb.2009.12.010_bib0535","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1124\/mol.106.028902","article-title":"Pioglitazone inhibits androgen production in NCI-H295R cells by regulating gene expression of CYP17 and HSD3B2","volume":"71","author":"Kempna","year":"2007","journal-title":"Mol. Pharmacol."},{"issue":"12","key":"10.1016\/j.jsbmb.2009.12.010_bib0540","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1210\/jc.2007-1394","article-title":"The mechanism for protein kinase C inhibition of androgen production and 17alpha-hydroxylase expression in a theca cell tumor model","volume":"92","author":"Beshay","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.jsbmb.2009.12.010_bib0545","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1210\/jc.2007-1834","article-title":"Impact of obesity on the risk for polycystic ovary syndrome","volume":"93","author":"Yildiz","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.jsbmb.2009.12.010_bib0550","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/humrep\/den211","article-title":"Obesity, body composition and metabolic disturbances in polycystic ovary syndrome","volume":"23","author":"Svendsen","year":"2008","journal-title":"Hum. Reprod."},{"issue":"5249","key":"10.1016\/j.jsbmb.2009.12.010_bib0555","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1126\/science.271.5249.665","article-title":"IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance","volume":"271","author":"Hotamisligil","year":"1996","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.jsbmb.2009.12.010_bib0560","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1210\/edrv.20.4.0374","article-title":"The insulin-related ovarian regulatory system in health and disease","volume":"20","author":"Poretsky","year":"1999","journal-title":"Endocr. Rev."},{"issue":"7","key":"10.1016\/j.jsbmb.2009.12.010_bib0565","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.ijo.0801994","article-title":"Obesity and the polycystic ovary syndrome","volume":"26","author":"Gambineri","year":"2002","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"issue":"6","key":"10.1016\/j.jsbmb.2009.12.010_bib0570","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0015-0282(03)00265-6","article-title":"Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome","volume":"79","author":"Yildirim","year":"2003","journal-title":"Fertil. Steril."},{"issue":"4","key":"10.1016\/j.jsbmb.2009.12.010_bib0575","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1046\/j.1365-2265.2001.01375.x","article-title":"Clinical features in women with polycystic ovaries: relationships to insulin sensitivity, insulin gene VNTR and birth weight","volume":"55","author":"Michelmore","year":"2001","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"7","key":"10.1016\/j.jsbmb.2009.12.010_bib0580","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1055\/s-2007-1009245","article-title":"Anthropometric variables and metabolism in polycystic ovarian disease","volume":"21","author":"Rebuffe-Scrive","year":"1989","journal-title":"Horm. Metab. Res."},{"issue":"10","key":"10.1016\/j.jsbmb.2009.12.010_bib0585","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/j.1471-0528.2006.00990.x","article-title":"The impact of obesity on reproduction in women with polycystic ovary syndrome","volume":"113","author":"Pasquali","year":"2006","journal-title":"Bjog-An Int. J. Obstet. Gynaecol."},{"issue":"5","key":"10.1016\/j.jsbmb.2009.12.010_bib0590","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2217\/WHE.09.39","article-title":"Polycystic ovary syndrome, obesity and reproductive implications","volume":"5","author":"Hirschberg","year":"2009","journal-title":"Womens Health (Lond. Engl.)"},{"issue":"3","key":"10.1016\/j.jsbmb.2009.12.010_bib0595","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1467-789X.2004.00147.x","article-title":"Effects of obesity on women's reproduction and complications during pregnancy","volume":"5","author":"Linne","year":"2004","journal-title":"Obes. Rev."},{"issue":"6","key":"10.1016\/j.jsbmb.2009.12.010_bib0600","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1210\/jcem-52-6-1246","article-title":"Obesity and its role in polycystic ovary syndrome","volume":"52","author":"Plymate","year":"1981","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.jsbmb.2009.12.010_bib0605","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2009.12.010_bib0610","doi-asserted-by":"crossref","unstructured":"J.P. Baillargeon, N.R. Farid, Medical treatment, in: Diagnosis and Management of Polycystic Ovarian Disease, Springer Science+Business Media Inc., New York, 2009, pp. 209\u2013232.","DOI":"10.1007\/978-0-387-09718-3_18"},{"issue":"3","key":"10.1016\/j.jsbmb.2009.12.010_bib0615","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.fertnstert.2007.09.041","article-title":"Consensus on infertility treatment related to polycystic ovary syndrome","volume":"89","author":"Anon.","year":"2008","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsbmb.2009.12.010_bib0620","article-title":"An assessment of lifestyle modification versus medical treatment with clomiphene citrate, metformin, and clomiphene citrate-metformin in patients with polycystic ovary syndrome","author":"Karimzadeh","year":"2009","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsbmb.2009.12.010_bib0625","article-title":"Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: a randomized, double-blind, and placebo control trial","author":"Fux","year":"2009","journal-title":"Gynecol. Endocrinol."},{"issue":"2","key":"10.1016\/j.jsbmb.2009.12.010_bib0630","first-page":"353","article-title":"Current trends in the treatment of polycystic ovary syndrome with desire for children","volume":"5","author":"Sastre","year":"2009","journal-title":"Ther. Clin. Risk Manag."},{"issue":"5","key":"10.1016\/j.jsbmb.2009.12.010_bib0635","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.bpobgyn.2004.05.003","article-title":"Understanding and managing disturbances in insulin metabolism and body weight in women with polycystic ovary syndrome","volume":"18","author":"Moran","year":"2004","journal-title":"Best. Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"2","key":"10.1016\/j.jsbmb.2009.12.010_bib0640","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1210\/jc.2002-020815","article-title":"Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome","volume":"88","author":"Moran","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.jsbmb.2009.12.010_bib0645","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.fertnstert.2003.08.023","article-title":"A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome","volume":"81","author":"Stamets","year":"2004","journal-title":"Fertil. Steril."},{"issue":"2","key":"10.1016\/j.jsbmb.2009.12.010_bib0650","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1210\/jc.2003-030666","article-title":"Metabolic and endocrine effects of a polyunsaturated fatty acid-rich diet in polycystic ovary syndrome","volume":"89","author":"Kasim-Karakas","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.jsbmb.2009.12.010_bib0655","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.fertnstert.2005.08.045","article-title":"Role of diet in the treatment of polycystic ovary syndrome","volume":"85","author":"Douglas","year":"2006","journal-title":"Fertil. Steril."},{"issue":"4","key":"10.1016\/j.jsbmb.2009.12.010_bib0660","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4158\/EP.7.4.279","article-title":"Use of insulin-sensitizing agents in patients with polycystic ovary syndrome","volume":"7","author":"Bloomgarden","year":"2001","journal-title":"Endocr. Pract."},{"issue":"12","key":"10.1016\/j.jsbmb.2009.12.010_bib0665","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.metabol.2006.08.001","article-title":"Sustainability of 8% weight loss, reduction of insulin resistance, and amelioration of atherogenic-metabolic risk factors over 4 years by metformin-diet in women with polycystic ovary syndrome","volume":"55","author":"Glueck","year":"2006","journal-title":"Metabolism"},{"issue":"6","key":"10.1016\/j.jsbmb.2009.12.010_bib0670","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/humrep\/del025","article-title":"The use of metformin for women with PCOS undergoing IVF treatment","volume":"21","author":"Tang","year":"2006","journal-title":"Hum. Reprod."},{"issue":"11","key":"10.1016\/j.jsbmb.2009.12.010_bib0675","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/BF03345339","article-title":"The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome","volume":"28","author":"Yilmaz","year":"2005","journal-title":"J. Endocrinol. Invest."},{"issue":"4","key":"10.1016\/j.jsbmb.2009.12.010_bib0680","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/09513590701260193","article-title":"Effects of metformin treatment in women with polycystic ovary syndrome depends on insulin resistance","volume":"23","author":"Nawrocka","year":"2007","journal-title":"Gynecol. Endocrinol."},{"issue":"5","key":"10.1016\/j.jsbmb.2009.12.010_bib0685","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1530\/EJE-07-0294","article-title":"Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance","volume":"157","author":"Tan","year":"2007","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.jsbmb.2009.12.010_bib0690","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.fertnstert.2003.08.012","article-title":"Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin","volume":"81","author":"Maciel","year":"2004","journal-title":"Fertil. Steril."},{"issue":"4","key":"10.1016\/j.jsbmb.2009.12.010_bib0695","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0015-0282(02)04925-7","article-title":"Metformin has direct effects on human ovarian steroidogenesis","volume":"79","author":"Mansfield","year":"2003","journal-title":"Fertil. Steril."},{"issue":"10","key":"10.1016\/j.jsbmb.2009.12.010_bib0700","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.1210\/en.2009-0540","article-title":"Metformin inhibits aromatase via an ERK (extracellular signal-regulated kinase)\u2014mediated pathway","volume":"150","author":"Rice","year":"2009","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.jsbmb.2009.12.010_bib0705","first-page":"1626","article-title":"Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial","volume":"86","author":"Azziz","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.jsbmb.2009.12.010_bib0710","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1210\/jc.2003-031737","article-title":"Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome","volume":"89","author":"Brettenthaler","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.jsbmb.2009.12.010_bib0715","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1210\/jc.2008-1133","article-title":"Metabolic and hormonal changes induced by pioglitazone in polycystic ovary syndrome: a randomized, placebo-controlled clinical trial","volume":"94","author":"Aroda","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.jsbmb.2009.12.010_bib0720","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1210\/jc.2004-1376","article-title":"Effects of rosiglitazone in obese women with polycystic ovary syndrome and severe insulin resistance","volume":"90","author":"Sepilian","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Pt 3","key":"10.1016\/j.jsbmb.2009.12.010_bib0725","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1258\/acb.2008.008146","article-title":"The mean and the biological variation of insulin resistance does not differ between polycystic ovary syndrome and type 2 diabetes","volume":"46","author":"Cho","year":"2009","journal-title":"Ann. Clin. Biochem."},{"issue":"3","key":"10.1016\/j.jsbmb.2009.12.010_bib0730","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1210\/jcem.87.3.8308","article-title":"Troglitazone, an insulin-sensitizing thiazolidinedione, represses combined stimulation by LH and insulin of de novo androgen biosynthesis by thecal cells in vitro","volume":"87","author":"Veldhuis","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.jsbmb.2009.12.010_bib0735","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1095\/biolreprod66.1.190","article-title":"Putative activation of the peroxisome proliferator-activated receptor gamma impairs androgen and enhances progesterone biosynthesis in primary cultures of porcine theca cells","volume":"66","author":"Schoppee","year":"2002","journal-title":"Biol. Reprod."},{"issue":"11","key":"10.1016\/j.jsbmb.2009.12.010_bib0740","doi-asserted-by":"crossref","first-page":"6099","DOI":"10.1210\/jc.2005-0469","article-title":"Direct thiazolidinedione action in the human ovary: insulin-independent and insulin-sensitizing effects on steroidogenesis and insulin-like growth factor binding protein-1 production","volume":"90","author":"Seto-Young","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076009003033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076009003033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:36:45Z","timestamp":1760744205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076009003033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":148,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0960076009003033"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2009.12.010","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insulin and hyperandrogenism in women with polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2009.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}